Information on TIACM

Basic details

Name: T-cell immunodeficiency, autoimmunity, and cardiac malformations | Acronym: TIACM
Alt. names: T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations

Gene: STK4 | MOI: Autosomal recessive | Mechanism of action:

No. of cases in DB: 1 | First reported in: 2012

Last updated on: 2023-02-28 16:41:18 by

OMIM: 614868

Orphanet: -

MONDO: -

DOID: -

ClinGen:

Description

Individuals are susceptible to recurrent and severe viral, bacterial, and fungal infections (as well as sequelae such as EBV-related lymphoma), and and prophylaxis, as well as prompt and aggressive treatment of infections may be beneficial; Individuals may have cardiovascular anomalies, and surveillance (including with echocardiogram) may allow early detection and management; HSCT has been described. Refs. PMIDs: 22294732; 22174160

Management

Description of management option has not been reviewed yet.

Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.

1 reported cases added to GenIA

SubjectID Sex Fam.ID AD AFM Validity Country Population Reference & Pub.code
105409arrow icon M 215759 PMID:33382390 [Patient 1]

AD: Age at genetic diagnosis; AFM: age at first manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).

Summary of clinical findings

[Considering only Definitive and Possible cases]

Rank Clinical term Present Absent Unreported
1 Lymphopeniaarrow icon 11 (78.6%) 0 (0.0%) 3 (21.4%)
2 Childhood onsetarrow icon 5 (71.4%) 0 (0.0%) 2 (28.6%)
3 Neutropeniaarrow icon 5 (71.4%) 0 (0.0%) 2 (28.6%)
4 Bronchiectasisarrow icon 3 (75.0%) 0 (0.0%) 1 (25.0%)
5 Mucocutaneous candidiasisarrow icon 3 (99.9%) 0 (0.0%) 0 (0.0%)
6 Immunodeficiencyarrow icon 3 (99.9%) 0 (0.0%) 0 (0.0%)
7 Patent foramen ovalearrow icon 3 (99.9%) 0 (0.0%) 0 (0.0%)
8 Persistent EBV viremiaarrow icon 3 (75.0%) 0 (0.0%) 1 (25.0%)
9 repeated bacterial infectionsarrow icon 3 (99.9%) 0 (0.0%) 0 (0.0%)
10 Recurrent pneumoniaarrow icon 3 (42.9%) 0 (0.0%) 4 (57.1%)
11 Recurrent sinusitisarrow icon 3 (42.9%) 0 (0.0%) 4 (57.1%)
12 Skin infections arrow icon 3 (42.9%) 0 (0.0%) 4 (57.1%)
13 Recurrent viral infectionsarrow icon 3 (99.9%) 0 (0.0%) 0 (0.0%)
14 Wartsarrow icon 3 (99.9%) 0 (0.0%) 0 (0.0%)
15 Recurrent lower respiratory tract infectionsarrow icon 2 (28.6%) 0 (0.0%) 5 (71.4%)
16 Recurrent upper respiratory tract infectionarrow icon 2 (66.7%) 0 (0.0%) 1 (33.3%)
17 Secundum atrial septal defectarrow icon 2 (66.7%) 0 (0.0%) 1 (33.3%)
18 Septicaemiaarrow icon 2 (66.7%) 0 (0.0%) 1 (33.3%)
19 Autoimmune hemolytic anemiaarrow icon 1 (25.0%) 0 (0.0%) 3 (75.0%)
20 Disseminated molluscum contagiosumarrow icon 1 (25.0%) 0 (0.0%) 3 (75.0%)
21 Hodgkin lymphomaarrow icon 1 (25.0%) 0 (0.0%) 3 (75.0%)
22 Infantile onsetarrow icon 1 (25.0%) 0 (0.0%) 3 (75.0%)
23 Juvenile onsetarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
24 Lymphoproliferative disorderarrow icon 1 (25.0%) 0 (0.0%) 3 (75.0%)
25 Molluscum contagiosumarrow icon 1 (25.0%) 0 (0.0%) 3 (75.0%)
26 Recurrent aphthous stomatitisarrow icon 1 (25.0%) 0 (0.0%) 3 (75.0%)
27 Recurrent feversarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)

Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.

Summary of treatment outcomes

[Considering only Definitive and Possible cases]

Treatment ⓘ Responses & clinical indications

Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.